I didn't listen to the CC yet, but, did Berger say if this was close to filling at this point? I imagine this cohort will be "oversubscribed" at some point...
Can someone refresh my memory what the endpoint are for analyzing data for submission in the PACE trial. I wonder if the fact that this trial is divided into cohorts they could possibly submit data in the T315i cohort earlier than the other cohorts?
At the very least, data will be piling in quicker than we all thought - and ASH is looking to be a huge event for this trial.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.